The Clayco Foundation and RVCL.org are excited and privileged to work with scientific and medical professionals around the world on various research projects that may aid the overall RVCL.org mission statements. One such researcher is Dr. Rejendra S. Apte MD, Ph.D. at Washington University in St. Louis.
Dr. Rajendra Apte is the Paul A. Cibis Distinguished Professor of Opthalmology and Visual Sciences, and his specialties include age-related macular degeneration, retinal issues, and several other biological mechanisms that may be related to RVCL progression. His expertise and research focus are significant value adds to our goals of identifying patients in a more efficient manner.
It has been well established that RVCL patients suffer from retinal lesions and associated problems, though the extent and measurability of these retinal changes are still not fully understood. If further studied, it is possible that a more conclusive ‘retinal signature’ could be discovered that may help diagnose future RVCL patients in a quicker, more beneficial manner. In addition to diagnosability, a better-detailed understanding of RVCL associated eye problems may help guide treatment options and responses.
Therefore, The Clayco Foundation has provided research funds to Dr. Apte to advance the project: Determining the extent to which retinal changes can be used as an RVCL diagnostic biomarker, and exploring how new therapies may benefit overall eye health in RVCL patients. The results from this research could be a ‘game-changer’ in identifying RVCL patients sooner, augmenting clinical trials, and a stronger ability to determine which treatments may or may not be efficacious. As studies continue, we will be sure to update our site and invite you to follow us.